Turkey Adds 32 Drugs to Reimbursement List, Boosting Domestic Production

Turkey's Social Security Institution (SGK) has expanded its list of reimbursed medications, adding 32 new drugs. This expansion aims to enhance citizens' access to essential treatments and bolster the nation's healthcare capabilities.

Minister of Labor and Social Security Vedat Işıkhan announced the update via his social media account. He highlighted that 21 of the newly added medications are locally produced. This focus on domestic production aligns with the government's strategy to strengthen national capacity in the healthcare sector.

"We have added 32 more drugs to the reimbursement list through our Social Security Institution," Işıkhan stated. "With 21 of these drugs being domestically produced, we are strengthening our local and national capacity in healthcare and making it easier for our citizens to access treatment options."

The minister expressed his hope that these medications will bring healing to patients and wished citizens a healthy life. The inclusion of these drugs on the SGK's list is expected to reduce out-of-pocket expenses for patients and ensure wider availability of necessary pharmaceuticals across the country.